14-day RSI
63.06
+9.51+17.76%
27 November 2024
Summary:
Inhibikase Therapeutics stock 14-day relative strength index is 63.06, with the most recent change of +9.51 (+17.76%) on 27 November 2024. According to this value, IKT stock is neither oversold nor overboughtIKT RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +17.8% | +11.6% | +1.6% | +0.1% |
| 1 m1 month | -12.4% | +7.3% | +36.6% | +0.5% |
| 3 m3 months | +23.3% | +85.7% | +43.4% | +4.7% |
| 6 m6 months | +19.1% | +36.8% | +6.2% | +4.0% |
| ytdytd | +11.8% | +109.7% | +90.7% | -27.3% |
| 1 y1 year | +47.8% | +198.8% | +94.1% | -36.6% |
| 5 y5 years | - | - | - | - |
IKT RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 76.89 | -18.0% | 40.35 | +56.3% |
| 3 m | 3 months | 86.50 | -27.1% | 33.94 | +85.8% |
| 6 m | 6 months | 86.50 | -27.1% | 31.58 | +99.7% |
| 1 y | 1 year | 88.70 | -28.9% | 19.73 | +219.6% |
| 3 y | 3 years | 88.70 | -28.9% | 18.01 | +250.1% |
| 5 y | 5 years | 88.70 | -28.9% | 0.00 | -100.0% |
| alltime | all time | 88.70 | -28.9% | 0.00 | -100.0% |
Inhibikase Therapeutics Stock RSI History
| Date | Value |
|---|---|
| 2024 | 63.06(+11.8%) |
| 2023 | 56.40(+33.4%) |
| Date | Value |
|---|---|
| 2022 | 42.28(+10.7%) |
| 2021 | 38.18(>+9900.0%) |
| 2020 | 0.00 |
FAQ
- What is Inhibikase Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Inhibikase Therapeutics?
What is Inhibikase Therapeutics 14-day relative strength index?
The current 14-day RSI of IKT is 63.06
What is the all time high 14-day RSI for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high 14-day relative strength index is 88.70